Atrial Fibrillation Detection Using Garmin Wearable Technology

University of Kansas Medical Center120 enrolled

Overview

The purpose of this study is to evaluate the feasibility of detecting atrial fibrillation (AF) in patients with AF using a wearable wrist device/smart watch.

Even though AF is common and associated with increased risk of stroke, quite often it goes undetected until late in the course of the condition. If AF can be detected with simpler tools like a smart watch, it would enable providers to identify patients with AF much earlier in the course of the condition (even before being seen by a physician) and hopefully be able to prevent stroke. This study is being done to identify a technology that can likely identify AF using a smart watch.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Atrial Fibrillation

Interventions

Garmin Smart WatchDEVICE

Garmin Smart Watch

Garmin Chest BandDEVICE

Garmin Chest Band

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with AF scheduled to undergo electrical cardioversion at the University of Kansas Health System Exclusion Criteria: * Patients with no detectable PPG * Hemodynamically unstable patients * Patients who cannot give informed consent * Patients with tattoos on the wrists

Locations (1)

University of Kansas Medical Center

Kansas City, Kansas, United States

RECRUITING

Outcomes

Primary Outcomes

Sensitivity and specificity of Garmin wearable device in detecting AF

PPG samples collected from Garmin wearable will be evaluated and calculated by Garmin custom

Time frame: Visit 1

Central Contacts

Margana Morgan

CONTACT

913-945-6443 mmorgan@kumc.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.